| Mar'12 | Mar'11 | ||||
|---|---|---|---|---|---|
Net income | |||||
86,300 | 10,200 | ||||
Depreciation, depletion and amortization | |||||
22,100 | 13,100 | ||||
Deferred income taxes | |||||
100 | -1,600 | ||||
Amortization of debt issuance costs | |||||
800 | 100 | ||||
Pension and postretirement healthcare benefit (income) expense, net | |||||
1,300 | 800 | ||||
Stock compensation expense | |||||
-6,700 | -2,900 | ||||
Other noncash items affecting net income | |||||
-2,300 | -3,400 | ||||
(Increase) decrease in trade accounts receivable | |||||
77,500 | 59,500 | ||||
(Increase) decrease in related parties accounts receivable | |||||
-5,200 | 1,600 | ||||
(Increase) decrease in inventories | |||||
93,200 | -33,500 | ||||
(Increase) decrease in prepaids and other assets | |||||
400 | 300 | ||||
Increase (decrease) in accounts payable and accrued liabilities | |||||
7,600 | -58,500 | ||||
Increase (decrease) in related parties accounts payable | |||||
-2,200 | 17,500 | ||||
Increase (decrease) in taxes payable | |||||
15,300 | 4,300 | ||||
Other, net | |||||
200 | -31,500 | ||||
Cash used in operating activities | |||||
-25,800 | -4,200 | ||||
Capital expenditures | |||||
20,700 | 8,300 | ||||
Proceeds from sale of assets | |||||
0 | 0 | ||||
Cash used in investing activities | |||||
-20,700 | -8,300 | ||||
Reductions of debt | |||||
421,100 | 1,100 | ||||
Proceeds from borrowings | |||||
550,000 | 14,000 | ||||
Debt issuance costs and commitment fees | |||||
19,000 | - | ||||
Other equity, net | |||||
300 | - | ||||
Cash provided by financing activities | |||||
110,200 | 12,900 | ||||
Effects of Exchange Rate Changes on Cash and Cash Equivalents | |||||
5,000 | 400 | ||||
Net Increase (Decrease) in Cash and Cash Equivalents | |||||
68,700 | 800 | ||||